0001645966-15-000001.txt : 20150714 0001645966-15-000001.hdr.sgml : 20150714 20150714091117 ACCESSION NUMBER: 0001645966-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150714 DATE AS OF CHANGE: 20150714 EFFECTIVENESS DATE: 20150714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ballantyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001645966 IRS NUMBER: 472125610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-243626 FILM NUMBER: 15986564 BUSINESS ADDRESS: STREET 1: 7805 PEMSWOOD STREET CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 704-807-6502 MAIL ADDRESS: STREET 1: 7805 PEMSWOOD STREET CITY: CHARLOTTE STATE: NC ZIP: 28277 D 1 primary_doc.xml X0707 D LIVE 0001645966 Ballantyne Therapeutics, Inc. 7805 PEMSWOOD STREET CHARLOTTE NC NORTH CAROLINA 28277 704-807-6502 DELAWARE None None Corporation true 2014 Michael Roberts c/o Ballantyne Therapeutics, Inc. 7805 Pemswood Street Charlotte NC NORTH CAROLINA 28277 Executive Officer Director Simon Pedder c/o Ballantyne Therapeutics, Inc. 7805 Pemswood Street Charlotte NC NORTH CAROLINA 28277 Director Pharmaceuticals Decline to Disclose 06b false 2015-05-08 false true false 0 500000 400000 100000 false 7 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. false Ballantyne Therapeutics, Inc. /s/ Michael Roberts Michael Roberts Chief Executive Officer 2015-06-18